(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Upcoming Financial Results: Salesforce, CrowdStrike, NetApp, Okta, Donaldson - Expectations and Market Updates

May 27th, 2023

On Wednesday, May 31, several companies are expected to report their financial results. Here is an overview of the information related to each company: Salesforce, Inc. (NYSE: CRM) will release its first-quarter fiscal year 2024 results after the . Read more

Earnings Reports for the Week Ahead: Tsakos Energy Navigation, UP Fintech, Agora, Yatra Online, MediWound

May 27th, 2023

On Tuesday, May 30, several companies are expected to report their financial results.  Tsakos Energy Navigation Limited (NYSE: TNP) will announce its earnings for the first quarter of 2023 before the opening of the New York market. Analysts a. Read more

FDA's Decision Boost Stock Prices for Lexicon Pharmaceuticals and Iovance Biotherapeutics

May 27th, 2023

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that the FDA has granted approval for their once-daily oral tablet, INPEFA (sotagliflozin).  This medication aims to reduce the risk of cardiovascular death, hospitalization for heart fai. Read more

The Week On The Horizon: HP, U-Haul, Elbit Systems, Skyline Champion, JOYY - Key Insights and Expectations

May 27th, 2023

On Tuesday, May 30, several companies will be reporting their financial results.  HP Inc. (NYSE: HPQ) is set to release its second-quarter fiscal 2023 results after the market closes. Analysts expect an EPS of $0.76 on revenue of $13.09 billi. Read more

Racing to Develop the Next-Generation Lunar Terrain Vehicle (LTV) for NASA's Artemis Missions: Lockheed Martin, Northrop Grumman, Teledyne, Leidos, Astrolab

May 26th, 2023

NASA made an announcement on Friday, revealing its search for industry proposals for the development of a next-generation Lunar Terrain Vehicle (LTV). The purpose of this advanced vehicle is to enable astronauts to explore the south polar region of t. Read more

Analysts Bullish on Guardant Health, New Relic, OPAL Fuels; Diana Shipping Beats Estimates

May 26th, 2023

Diana Shipping Inc. (NYSE: DSX) has released its financial results for the first quarter of 2023, reporting earnings per share (EPS) of $0.22, surpassing the consensus estimate of $0.14. In light of its performance, the company has declared a dividen. Read more

Positive Pre-Market Momentum for Quhuo, Lyra Therapeutics and Marinus Pharmaceuticals

May 26th, 2023

Quhuo Limited (Nasdaq: QH) announced remarkable achievements in its homestay sector operated by Chengtu Home during the Labor Day holiday.  According to Quhuo, they recorded an impressive average daily occupancy rate of 95%, representing a si. Read more

Financial Results: Big Lots Reports Q1 Loss, PDD Surpasses Estimates, and LightInTheBox Achieves Record-breaking Quarter

May 26th, 2023

Big Lots, Inc. (NYSE: BIG) has announced its financial results for the first quarter of fiscal 2023, revealing an adjusted loss of $3.40 per share. This result is in contrast to the consensus estimate of a loss of $1.77 per share..  The compa. Read more

Corporate Earnings, Revised Guidance, and Medical Breakthroughs: Insights on Hibbett, Booz Allen Hamilton, and Novo Nordisk

May 26th, 2023

Hibbett, Inc. (Nasdaq: HIBB) released its first-quarter fiscal 2024 earnings per share (EPS) of $2.74, falling short of the consensus estimate of $3.04.  The company revised its full-year fiscal 2024 guidance to reflect a more cautious consum. Read more

Financial Performance and Clinical Updates: 23andMe, RH, and Aravive - Latest Reports and Future Prospects

May 26th, 2023

In the world of financial markets and healthcare, several companies have recently reported their financial performance and provided updates on their ongoing trials and future prospects. Genetic testing company 23andMe Holding Co. (Nasdaq: ME) disc. Read more